Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Advanced Adenomas (AA) clinical trials

1 of 1 indexed Advanced Adenomas (AA) trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Advanced Adenomas (AA): 1 US clinical trial tracked, 1 recruiting.

Advanced Adenomas (AA) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Universal Diagnostics, running 1 of these trials.

Enrollment posture brief

Registry condition advanced-adenomas-aa

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Advanced Adenomas (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Advanced Adenomas (AA)

Advanced Adenomas (AA) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Advanced Adenomas (AA) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Advanced Adenomas (AA) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Advanced Adenomas (AA) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel Diagnostic test
1 trials

US sites by state

Facility locations filed on Advanced Adenomas (AA) trials. A trial with sites in several states counts in each.

Virginia 1 trials
Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
New York 1 trials
Massachusetts 1 trials
Louisiana 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Advanced Adenomas (AA) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Advanced Adenomas (AA) condition card totals 1 registered trials; most-linked intervention Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.